Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary focal hyperhidrosis: scope of the problem.

Dee Anna Glaser1, Adelaide A Hebert, David M Pariser

  • 1Department of Dermatology, Saint Louis University, Missouri, USA.

Cutis
|June 29, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Core Outcome Domain Set for Facial Aging.

JAMA dermatology·2026
Same author

Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

The Journal of dermatological treatment·2026
Same author

Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary.

The Journal of dermatological treatment·2026
Same author

Reconstitution, Storage, and Infection Outcomes of Botulinum Toxin in Academic Dermatology: A National Survey.

Journal of the American Academy of Dermatology·2026
Same author

Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel.

Journal of drugs in dermatology : JDD·2026
Same author

Innovation in pediatric atopic dermatitis care: examining emerging topical treatment options.

Expert review of clinical pharmacology·2026

Focal hyperhidrosis (HH) significantly impacts quality of life. Botulinum toxin type A (BTX-A) offers an effective and safe treatment option for palmar, plantar, and facial HH.

Area of Science:

  • Dermatology
  • Neurology

Background:

  • Focal hyperhidrosis (HH) severely diminishes patients' physical and emotional quality of life (QOL).
  • HH can lead to significant lifestyle and activity restrictions for affected individuals.

Purpose of the Study:

  • To review the efficacy and safety of available treatments for primary focal HH.
  • To highlight botulinum toxin type A (BTX-A) as a viable treatment option.

Main Methods:

  • Review of studies evaluating BTX-A (Botox) for palmar, plantar, and facial HH.
  • Assessment of treatment effectiveness, duration, and safety profile.

Main Results:

  • BTX-A demonstrates effective treatment for primary focal HH across various body areas.
  • The treatment offers a reasonable duration of effect and a favorable safety profile.

Related Experiment Videos

Conclusions:

  • BTX-A is a well-tolerated and effective therapeutic option for focal hyperhidrosis.
  • Physicians must stay informed about HH treatments to optimize patient care.